Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience.
Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience. Clin Transplant. 2023 05; 37(5):e14981.